SMITHS GROUP SERVICES CORPORATION for SMITHS GROUP SERVICES CORPORATION
What was lobbied
11 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Issues related to the North American Free Trade Agreement (NAFTA). Issues related to Section 301 and Section 232 tariffs.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| LILIA LORREIN RAMIREZ | — |
Defense DEF
Issues related to CBRNE (Chemical, Biological, Radiological, Nuclear and Explosives) technology and detection solutions for the Department of Defense. H.R.6157/S.3159, Department of Defense Appropriations Act, 2019. H.R.5515/S.2987, National Defense Authorization Act for Fiscal Year 2019.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| KEVIN SCHMIDT | — |
Taxation/Internal Revenue Code TAX
Tax issues affecting the industry, including repeal of the medical device excise tax. H.R.184, Protect Medical Innovation Act of 2017; S.108, Medical Device Access and Innovation Protection Act; H.R.4617, To amend the Internal Revenue Code of 1986 to provide for a temporary moratorium on the medical device excise tax.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA CEGLIA | — |
Health Issues HCR
Reimbursement and policy issues related to non-opioid acute pain management. S.3120, An original bill to amend titles XVIII and XIX of the Social Security Act to help end addictions and lessen substance abuse disorders, and for other purposes. H.R.6, SUPPORT for Patients and Communities Act.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA CEGLIA | — |
Medicare/Medicaid MMM
Patient infusion therapy and reimbursement/policy issues related to non-opioid acute pain management. S.1738, Medicare Home Infusion Therapy Access Act of 2017. H.R.3178, Medicare Part B Improvement Act of 2017. H.R.3163, Medicare Part B Home Infusion Services Temporary Transitional Payment Act. S.3120, An original bill to amend titles XVIII and XIX of the Social Security Act to help end addictions and lessen substance abuse disorders, and for other purposes. H.R.6, SUPPORT for Patients and Communities Act.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA CEGLIA | — |
Budget/Appropriations BUD
Funding for aviation security and homeland security technologies, including Transportation Security Administration (TSA) funding and chemical and biological counter measures. S.3109/House, Department of Homeland Security Appropriations Act, 2019, Transportation Security Administration (TSA) funding. H.R.6157/S.3159, Department of Defense Appropriations Act, 2019, Chemical Biological Funding. H.R.5952/S.3072, Commerce, Justice, Science, and Related Agencies Appropriations Act, 2019, Opioid Funding. S.3158/House, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019, Reimbursement for Medical Devices.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA CEGLIA | — |
| KEVIN SCHMIDT | — |
Environment/Superfund ENV
Issues related to climate change and emissions technologies.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA CEGLIA | — |
Aviation/Airlines/Airports AVI
Aviation security solutions and detection technologies for the Transportation Security Administration (TSA). H.R.2825, DHS Authorization Act.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| KEVIN SCHMIDT | — |
Homeland Security HOM
Issues related to aviation security solutions and detection technologies for the Transportation Security Administration (TSA), Department of Homeland Security (DHS), U.S. Customs and Border Protection (CBP) and the Domestic Nuclear Detection Office (DNDO). Issues related to CBRNE (Chemical, Biological, Radiological, Nuclear and Explosives) technology and other border security solutions. S.3109/House, Department of Homeland Security Appropriations Act, 2019.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| KEVIN SCHMIDT | — |
Medical/Disease Research/Clinical Labs MED
Issues related to patient infusion therapy, medical device tax, Medicare reimbursements for tracheotomy tubes, and medical device technology related to the opioid epidemic. Implementation of 21st Century Cures Act (P.L.114-255). S.1738, Medicare Home Infusion Therapy Access Act of 2017. H.R.3178, Medicare Part B Improvement Act of 2017. H.R.3163, Medicare Part B Home Infusion Services Temporary Transitional Payment Act. S.3120, An original bill to amend titles XVIII and XIX of the Social Security Act to help end addictions and lessen substance abuse disorders, and for other purposes. H.R.6, SUPPORT for Patients and Communities Act.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA CEGLIA | — |
Torts TOR
Issues related to tort reform. H.R.906, Furthering Asbestos Claim Transparency (FACT) Act of 2017. H.R.985, Fairness in Class Action Litigation and Furthering Asbestos Claim Transparency Act of 2017. H.R.3487, To amend section 1332 of title 28, United States Code, to provide that the requirement for diversity of citizenship jurisdiction is met if any one party to the case is diverse in citizenship from any one adverse party in the case.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA CEGLIA | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.